Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms

被引：0
|
作者：
Tashi, Tsewang [1 ]
Deininger, Michael W. [2 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Div Hematol & Hematol Malignancies, 2000 Circle Hope, Salt Lake City, UT 84112 USA
[2] Med Coll Wisconsin, Versiti Blood Res Inst, Div Hematol & Oncol, 8727 West Water town Plank Rd, Milwaukee, WI 53226 USA
来源：
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA | 2023年 / 43卷 / 04期
关键词：
Systemic mastocytosis; Associated hematologic neoplasm; KIT D816 V; KIT inhibitors; Tryptase; Avapritinib; MAST-CELL DISORDERS; C-KIT MUTATION; IMATINIB MESYLATE; TREATMENT OPTIONS; TYROSINE KINASE; RESPONSE CRITERIA; INTERFERON-ALPHA; TRYPTASE LEVELS; LEUKEMIA; EFFICACY;
D O I：
10.1016/j.iac.2023.04.009
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：723 / 741
页数：19
相关论文
共 50 条
  • [31] Systemic mastocytosis and other mast cell neoplasms
    Bain, BJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (01) : 9 - 17
  • [32] Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice
    Ustun, Celalettin
    Arock, Michel
    Kluin-Nelemans, Hanneke C.
    Reiter, Andreas
    Sperr, Wolfgang R.
    George, Tracy
    Horny, Hans-Peter
    Hartmann, Karin
    Sotlar, Karl
    Damaj, Gandhi
    Hermine, Olivier
    Verstovsek, Srdan
    Metcalfe, Dean D.
    Gotlib, Jason
    Akin, Cem
    Valent, Peter
    HAEMATOLOGICA, 2016, 101 (10) : 1133 - 1143
  • [33] KIT Inhibitors for the Treatment of Advanced Systemic Mastocytosis: Focus on the Elderly Patients
    Tsai, Guan-Jhe
    Lim, Ken-Hong
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (03) : 153 - 156
  • [34] Management of adult mastocytosis
    Alvarez-Twose, Ivan
    Matito, Almudena
    Sanchez-Munoz, Laura
    Mario Morgado, Jose
    Escribano, Luis
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 321 - 336
  • [35] Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis
    Mannelli, Francesco
    ANNALS OF HEMATOLOGY, 2021, 100 (02) : 337 - 344
  • [36] Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis
    John H. Baird
    Jason Gotlib
    Current Hematologic Malignancy Reports, 2018, 13 : 407 - 416
  • [37] Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis
    Pilkington, Hollie
    Smith, Sarah
    Roskell, Neil
    Iannazzo, Sergio
    FUTURE ONCOLOGY, 2022, 18 (13) : 1583 - 1594
  • [38] Systemic mastocytosis linked to acute myeloid leukemia
    Ustun, Celalettin
    SALUD I CIENCIA, 2011, 18 (02): : 176 - +
  • [39] Current concepts and treatment advances in systemic mastocytosis
    Georgin-Lavialle, S.
    Barete, S.
    Suarez, F.
    Lepelletier, Y.
    Bodemer, C.
    Dubreuil, P.
    Lortholary, O.
    Hermine, O.
    REVUE DE MEDECINE INTERNE, 2009, 30 (01): : 25 - 34
  • [40] Osteosclerosis associated to systemic mastocytosis
    Diehl, Maria
    Fantl, Dorotea
    Morandi, Ana
    Galich, Ana
    Garcia Rivello, Hernan
    Plantalech, Luisa
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2016, 50 (03): : 429 - 434
12345